RWA Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Buy |
29,158
+254
| +0.9% | +$28.2K | 0.04% | 198 |
|
|
2025
Q1 | $3.24M | Sell |
28,904
-3,533
| -11% | -$396K | 0.04% | 192 |
|
|
2024
Q4 | $3M | Sell |
32,437
-173
| -0.5% | -$16K | 0.04% | 204 |
|
|
2024
Q3 | $2.73M | Buy |
32,610
+1,290
| +4% | +$108K | 0.03% | 214 |
|
|
2024
Q2 | $2.15M | Sell |
31,320
-2,175
| -6% | -$149K | 0.03% | 228 |
|
|
2024
Q1 | $2.45M | Buy |
33,495
+291
| +0.9% | +$21.3K | 0.03% | 212 |
|
|
2023
Q4 | $2.69M | Buy |
33,204
+250
| +0.8% | +$20.3K | 0.04% | 197 |
|
|
2023
Q3 | $2.47M | Sell |
32,954
-321
| -1% | -$24.1K | 0.05% | 121 |
|
|
2023
Q2 | $2.56M | Buy |
+33,275
| New | +$2.56M | 0.06% | 113 |
|
|
2021
Q4 | – | Sell |
-3,323
| Closed | -$232K | – | 255 |
|
|
2021
Q3 | $232K | Hold |
3,323
| – | – | 0.02% | 228 |
|
|
2021
Q2 | $229K | Buy |
3,323
+42
| +1% | +$2.89K | 0.02% | 228 |
|
|
2021
Q1 | $212K | Buy |
+3,281
| New | +$212K | 0.02% | 232 |
|
|
2020
Q4 | – | Sell |
-3,352
| Closed | -$212K | – | 236 |
|
|
2020
Q3 | $212K | Sell |
3,352
-273
| -8% | -$17.3K | 0.02% | 202 |
|
|
2020
Q2 | $279K | Buy |
+3,625
| New | +$279K | 0.03% | 180 |
|
|
2018
Q3 | – | Sell |
-1,214
| Closed | -$86K | – | 426 |
|
|
2018
Q2 | $86K | Sell |
1,214
-45,813
| -97% | -$3.25M | 0.01% | 340 |
|
|
2018
Q1 | $3.55M | Sell |
47,027
-9,252
| -16% | -$697K | 0.46% | 54 |
|
|
2017
Q4 | $4.03M | Sell |
56,279
-10,513
| -16% | -$753K | 0.45% | 56 |
|
|
2017
Q3 | $5.41M | Buy |
66,792
+1,571
| +2% | +$127K | 0.61% | 41 |
|
|
2017
Q2 | $4.62M | Buy |
65,221
+3,114
| +5% | +$220K | 0.57% | 47 |
|
|
2017
Q1 | $4.22M | Buy |
+62,107
| New | +$4.22M | 0.55% | 49 |
|